Skip to main content
SpringerLink
Log in

Treatment by Radiophosphorus Versus Busulfan in Polycythemia Vera: A Randomized Trial (E.O.R.T.C.’s) “Leukemias and Hematosarcomas” Group

  • Chapter
Book cover Tactics and Strategy in Cancer Treatment

Abstract

Polycythemia vera is a relatively rare disease with an average annual incidence rate of from 0.6–1.6/100,000 population. The mean age of onset is 55–60 years, and there is an increasing annual incidence rate with advancing age. Males fall more often ill than females (approximately 2:1; [2, 13, 18]). The mean survival time of untreated patients is only about 18 months [2].

European Organisation for Research on the Treatment of Cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dameshek, W.: Some speculations on the myeloproliferative syndromes. Blood 6, 372 (1951).

    PubMed  CAS  Google Scholar 

  2. Gilbert, H. S. : Definition, clinical features and diagnosis of polycythemia vera. Clin. Haematol. 4, 263 (1975).

    PubMed  CAS  Google Scholar 

  3. Gurney, C. W.: Mechanisms underlying the polycythemias. In: Regulation of Hematopoiesis. Red Cell Production. Gordon, A. S. (ed.). New York: Appleton Century Crofts, Educational Division, Meredith Corporation, 1970, Vol I, p. 611.

    Google Scholar 

  4. Halnan, K. E., Russell, M. H.: Polycythemia vera. Comparison of survival and causes of death in patients managed with and without radiotherapy. Lancet (1965) II, 760.

    Article  Google Scholar 

  5. Harman, J. B., Ledlie, E. M.: Survival of polycythemia vera patients treated with radioactive phosphorus. Brit. Med. J. 2, 146 (1967).

    Article  PubMed  CAS  Google Scholar 

  6. Henning, K., Franke, W. J., Strietzel, M.: Eigene Erfahrungen in der Radiophosphorbehandlung bei Polycythaemia vera. Zschr. ges. inn. Med. 20, 14 (1965).

    Google Scholar 

  7. Hör, G., Pabst, H. W.: Radiophosphortherapie der Polycythaemia vera. Revue therapeutique 30, 789 (1973).

    PubMed  Google Scholar 

  8. Landaw, St. A.: Acute leukemia in polycythemia vera. Sem. Hematol. 13, 33 (1976).

    CAS  Google Scholar 

  9. Lawrence, J. H.: Polycythemia. Physiology, diagnosis, and treatment. New York: Grune and Stratton, 1955.

    Google Scholar 

  10. Lawrence, J. H., Windell, H. S., Donald, W. G.: Leukemia in polycythemia vera. Ann. intern. Med. 70, 763 (1969).

    PubMed  CAS  Google Scholar 

  11. Ledlie, E. M.: The incidence of leukemia in patients with polycythemia vera treated by 32P. Clin. Radiol. 11, 130 (1960).

    Article  PubMed  CAS  Google Scholar 

  12. Loeb, V.: Treatment of polycythemia vera. Clin. Haematol. 4, 441 (1975).

    PubMed  Google Scholar 

  13. Modan, B.: An epidemiological study of polycythemia vera. Blood 26, 657 (1965).

    PubMed  CAS  Google Scholar 

  14. Modan, B., Lilienfeld, A. N.: Polycythemia vera and leukemia: role of radiation. Treatment study of 1222 patients. Medicine 44, 305 (1965).

    Article  PubMed  CAS  Google Scholar 

  15. Modan, B.: Inter-relationship between polycythemia vera, leukemia, and myeloid metaplasia. Clin. Haematol. 4, 427 (1975).

    PubMed  CAS  Google Scholar 

  16. Osgood, E. E.: Polycythemia vera: age relationship and survival. Blood 26, 243 (1965).

    PubMed  CAS  Google Scholar 

  17. Perkins, J., Israels, M. C. G., Wilkinson, J. F.: Polycythemia vera: clinical studies on a series of 127 patients managed without radiation therapy. Quart. J. Med. 33, 499 (1964).

    PubMed  CAS  Google Scholar 

  18. Silverstein, M. N., Larnier, A. P.: Polycythemia vera, 1935–1969: an epidemiologic survey in Rochester, Minnesota. Mayo Clinic Proceedings 46, 771 (1971).

    Google Scholar 

  19. Tubiana, M. R., Flamant, Attie, E., Hayat, M.: A study of hematological complications occurring in patients with polycythemia vera treated with 32P. (Based on a series of 296 patients). Blood 32, 536 (1968).

    PubMed  CAS  Google Scholar 

  20. Urasinski, J., Mysik, M.: Die Therapie der Polycythaemia vera mit Busulfan (MyleranR). Bericht über die Behandlungsergebnisse von 40 Kranken. Folia haemat. (Leipzig) 94, 360 (1970).

    CAS  Google Scholar 

Download references

Authors
  1. H. O. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Mathé
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Hayat
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut de Cancérologie et d’Immunogénétique (INSERM), Hôpital Paul-Brousse, 14 - 16 Ave, 94800, Villejuif, France

    Georges Mathé

  2. Paul-Vaillant Couturier and Institut Gustave-Roussy, 16bis Ave. Paul-Vaillant Couturier, 94800, Villejuif, France

    Georges Mathé

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Klein, H.O., Mathé, G., Hayat, M. (1977). Treatment by Radiophosphorus Versus Busulfan in Polycythemia Vera: A Randomized Trial (E.O.R.T.C.’s) “Leukemias and Hematosarcomas” Group. In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81174-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81176-0

  • Online ISBN: 978-3-642-81174-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation